This bill aims to formally repeal the prescription drug affordability board in New Hampshire. It includes specific amendments to existing law, such as deleting the position of the executive director of the prescription drug affordability board from the salary schedule in RSA 94:1-a, I(b). Additionally, it repeals RSA 6:12, I(b)(384), which pertains to the administration fund for the board, and RSA 126-BB, which outlines the board's functions and responsibilities.

The effective date for this repeal is set for July 1, 2025. The bill is noted to have no fiscal impact, as the board has already been effectively dissolved by a previous legislative action (HB 2 from the 2025 session). Consequently, there are no expected changes in revenue or expenditures related to this repeal.

Statutes affected:
Introduced: 126-BB:1, 126-BB:2